Incremental Value of Diagnostic 131I SPECT/CT Fusion Imaging in the Evaluation of Differentiated Thyroid Carcinoma-Reference-Cited by-同舟云学术

Incremental Value of Diagnostic 131I SPECT/CT Fusion Imaging in the Evaluation of Differentiated Thyroid Carcinoma

Published:2008-12 Issue:6 Volume:191 Page:1785-1794
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Wong Ka Kit,Zarzhevsky Natalia,Cahill John M.,Frey Kirk A.,Avram Anca M.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference13 articles.

1. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

2. Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

3. Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940-1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients

4. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 2002; 113:241-260

5. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chapter 7: Radioactive Iodine Treatment in Differentiated Thyroid Cancer;Journal of Head & Neck Physicians and Surgeons;2024-01

2. Thyroid Cancer Bone Metastasis;Metastatic Bone Disease;2024

3. Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer;Clinical Nuclear Medicine;2023-12-01

4. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022

5. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022